AI echo INSIGHT study: A prospective blinded randomized trial of artificial intelligence echocardiogram interpretation.

Contemp Clin TrialsAug 9, 2026 (epub)
Clinical ResearchCardiology

Keane K Lee, Niranjan Kumar, Sahir Eusuff et al.

✦ AI-curated · Sources linked

In 30 seconds

The AI ECHO INSIGHT study is a prospective randomized controlled trial assessing the impact of artificial intelligence on transthoracic echocardiogram (TTE) interpretation. Conducted at Kaiser Permanente Northern California, it involved 1200 historical TTE studies. The primary outcome is the rate of substantial changes between preliminary and final reports, comparing AI-assisted interpretation to traditional methods.

Key findings

  • The study evaluates 1200 historical TTE studies across three interpretation workflows.
  • Primary outcome measures the rate of substantial changes between preliminary and final reports.
  • Secondary outcomes include cardiologist interpretation time and diagnostic accuracy.

Why it matters

This research addresses the growing demand for timely echocardiogram interpretations, which can enhance clinician efficiency and potentially reduce diagnostic delays, thereby improving patient care.

Source

Published in Contemp Clin Trials. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.